A novel frameshift mutation of Chediak-Higashi syndrome and treatment in the accelerated phase
AUTOR(ES)
Wu, X.L., Zhao, X.Q., Zhang, B.X., Xuan, F., Guo, H.M., Ma, F.T.
FONTE
Braz J Med Biol Res
DATA DE PUBLICAÇÃO
23/03/2017
RESUMO
Chediak-Higashi syndrome (CHS) is a rare autosomal recessive immunodeficiency disease characterized by frequent infections, hypopigmentation, progressive neurologic deterioration and hemophagocytic lymphohistiocytosis (HLH), known as the accelerated phase. There is little experience in the accelerated phase of CHS treatment worldwide. Here, we present a case of a 9-month-old boy with continuous high fever, hypopigmentation of the skin, enlarged lymph nodes, hepatosplenomegaly and lung infection. He was diagnosed with CHS by gene sequencing, and had entered the accelerated phase. After 8 weeks of therapy, the boy had remission and was prepared for allogenic stem cell transplantation.
Documentos Relacionados
- Four cases of Chédiak-Higashi syndrome
- Defective granulocyte chemotaxis in the Chediak-Higashi syndrome
- Secondary amyloidosis in a bull with Chediak-Higashi syndrome.
- Chediak-Higashi Syndrome and Premature Exfoliation of Primary Teeth
- The Familial Occurrence of the Chediak-Higashi Syndrome in Mink and Cattle